Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page
- ChecktodayChange DetectedThe Conditions section no longer displays 'Multiple Myeloma', and the MedlinePlus related topic entry 'MedlinePlus Genetics' (and the related topics header) has been removed.SummaryDifference0.2%

- Check7 days agoChange DetectedRevision label on the page updated from v3.6.5 to v3.6.6, indicating a minor site update. This change likely does not alter the study details or the information presented to users.SummaryDifference0.1%

- Check14 days agoChange DetectedAdded a line under Study Details showing '2015 ( U.S. NIH Grant/Contract )' to disclose NIH funding for the study. This provides contextual information about sponsorship without altering study criteria or outcomes.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This update reflects a minor refresh of the page's content or layout as tracked by the site's revision system.SummaryDifference0.1%

- Check43 days agoChange DetectedAdds the disease focus Multiple myeloma and a related topics link (MedlinePlus Genetics) to the page to clarify the study context and provide a nearby resource. The page revision is updated from v3.6.3 to v3.6.4.SummaryDifference0.2%

- Check50 days agoChange DetectedThe related topics section was altered by removing the header and the entries for 'Multiple myeloma' and 'MedlinePlus Genetics'.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.